Catalona WJ - Search Results

1

Characteristics of prostate cancers detected at prostate specific antigen levels less than 2.5 ng/ml.

Meeks JJ, Loeb S, Helfand BT, Kan D, Smith ND, Catalona WJ. Meeks JJ, et al. Among authors: catalona wj. J Urol. 2009 Jun;181(6):2515-8; discussion 2518-9. doi: 10.1016/j.juro.2009.01.102. Epub 2009 Apr 16. J Urol. 2009. PMID: 19371879 Free PMC article.

2

Accuracy of prostate weight estimation by digital rectal examination versus transrectal ultrasonography.

Loeb S, Han M, Roehl KA, Antenor JA, Catalona WJ. Loeb S, et al. Among authors: catalona wj. J Urol. 2005 Jan;173(1):63-5. doi: 10.1097/01.ju.0000145883.01068.5f. J Urol. 2005. PMID: 15592029

3

Contemporary survival results and the role of radiation therapy in patients with node negative seminal vesicle invasion following radical prostatectomy.

Eggener SE, Roehl KA, Smith ND, Antenor JA, Han M, Catalona WJ. Eggener SE, et al. Among authors: catalona wj. J Urol. 2005 Apr;173(4):1150-5. doi: 10.1097/01.ju.0000155158.79489.48. J Urol. 2005. PMID: 15758725

4

Use of 2.6 ng/ml prostate specific antigen prompt for biopsy in men older than 60 years.

Nadler RB, Loeb S, Roehl KA, Antenor JA, Eggener S, Catalona WJ. Nadler RB, et al. Among authors: catalona wj. J Urol. 2005 Dec;174(6):2154-7, discussion 2157. doi: 10.1097/01.ju.0000181213.07447.8f. J Urol. 2005. PMID: 16280754

5

Baseline prostate-specific antigen compared with median prostate-specific antigen for age group as predictor of prostate cancer risk in men younger than 60 years old.

Loeb S, Roehl KA, Antenor JA, Catalona WJ, Suarez BK, Nadler RB. Loeb S, et al. Among authors: catalona wj. Urology. 2006 Feb;67(2):316-20. doi: 10.1016/j.urology.2005.08.040. Epub 2006 Jan 25. Urology. 2006. PMID: 16442597

6

Pathological characteristics of prostate cancer detected through prostate specific antigen based screening.

Loeb S, Gonzalez CM, Roehl KA, Han M, Antenor JA, Yap RL, Catalona WJ. Loeb S, et al. Among authors: catalona wj. J Urol. 2006 Mar;175(3 Pt 1):902-6. doi: 10.1016/S0022-5347(05)00327-7. J Urol. 2006. PMID: 16469576

7

Viewpoint: expanding prostate cancer screening.

Catalona WJ, Loeb S, Han M. Catalona WJ, et al. Ann Intern Med. 2006 Mar 21;144(6):441-3. doi: 10.7326/0003-4819-144-6-200603210-00012. Ann Intern Med. 2006. PMID: 16549857

8

Making prostate-specific antigen testing more effective.

Catalona WJ, Loeb S. Catalona WJ, et al. Urol Oncol. 2006 May-Jun;24(3):177-9. doi: 10.1016/j.urolonc.2005.09.001. Urol Oncol. 2006. PMID: 16678045 No abstract available.

9

Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progression.

Loeb S, Roehl KA, Yu X, Antenor JA, Han M, Gashti SN, Yang XJ, Catalona WJ. Loeb S, et al. Among authors: catalona wj. Urology. 2006 Jul;68(1):99-103. doi: 10.1016/j.urology.2006.02.004. Epub 2006 Jun 27. Urology. 2006. PMID: 16806410

10

Comparison of methods for calculating prostate specific antigen velocity.

Yu X, Han M, Loeb S, Gashti SN, Yeh JT, Roehl KA, Catalona WJ. Yu X, et al. Among authors: catalona wj. J Urol. 2006 Dec;176(6 Pt 1):2427-31; discussion 2431. doi: 10.1016/j.juro.2006.08.006. J Urol. 2006. PMID: 17085120

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

523 results

Search Page

Filters